Tweet by Beverly G. Tchang, MD on Twitter

vJliv5ks_normal.jpg spacer.png
Beverly G. Tchang, MD
⁦‪@BevTchangMD‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
Many patients with #diabetes are asking about Mounjaro because they are not tolerating other GLP1s and hoping for the newest #weightloss med. Do we think it will have fewer side effects than Ozempic/Wegovy?

⁦‪@MichaelAlbertMD‬⁩ ⁦‪@DrKarlNadolsky‬⁩ ⁦‪@obsmchat‬⁩ #obsm #endocrine #obesity

5/31/22, 10:25 AM

Joseph Thornton

Published by Joseph Thornton MD

Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own.

Leave a comment